Identification of the cytoplasmic regions of fibroblast growth factor (FGF) receptor 1 which play important roles in induction of neurite outgrowth in PC12 cells by FGF-1

Molecular and Cellular Biology

Volumn 18, Issue 7, 1998, Pages 3762-3770

  Lin, Hsien Yi ^a,c   Xu, Jingsong ^b   Ischenko, Irene ^a   Ornitz, David M ^b   Halegoua, Simon ^a   Hayman, Michael J ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CHIMERA; ENZYME ACTIVATION; MITOGENESIS; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031806908     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.7.3762     Document Type: Article

References (49)

1. Basilico, C., and D. Moscatelli. 1992. The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59:115-165.
2. Bellus, G. A., I. McIntosh, E. A. Smith, A. S. Aylsworth, I. Kaitila, W. A. Horton, G. A. Greenhaw, J. T. Hecht, and C. A. Francomano. 1995. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet. 10:357-359.
3. Chellaiah, A. T., D. G. McEwen, S. Werner, J. Xu, and D. M. Ornitz. 1994. Fibroblast growth factor receptor (FGFR) 3: alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. Biol. Chem. 269:11620-11627.
4. Chirgwin, J. M., A. E. Prezbyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
5. Colvin, J. S., B. A. Bohne, G. W. Harding, D. G. McEwen, and D. M. Ornitz. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12:390-397.
6. Coulier, F., P. Pontarotti, R. Roubin, H. Hartung, M. Goldfarb, and D. Birnbaum. 1997. Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J. Mol. Evol. 44:43-56.
7. D'Arcangelo, G., and S. Halegoua. 1993. A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions. Mol. Cell. Biol. 13:3146-3155.
8. Deng, C., A. Wynshaw-Boris, F. Zhou, A. Kuo, and P. Leder. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921.
9. Deng, C. X., A. Wynshaw-Boris, M. M. Shen, C. Daugherty, D. M. Ornitz, and P. Leder. 1994. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8:3045-3057.
10. Di Fiore, P. P., K. Helin, M. H. Kraus, J. H. Pierce, J. Artrip, O. Segatto, and D. P. Bottaro. 1992. A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2. EMBO J. 11:3927-3933.
11. Dikic, I., J. Schlessinger, and I. Lax. 1994. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr. Biol. 4:702-708.
12. Gao, G., and M. Goldfarb. 1995. Heparin can activate a receptor tyrosine kinase. EMBO J. 14:2183-2190.
13. Heasley, L. E., and G. L. Johnson. 1992. The beta-PDGF receptor induces neuronal differentiation of PC12 cells. Mol. Biol. Cell 3:545-553.
14. Hempstead, B. L., S. J. Rabin, L. Kaplan, S. Reid, L. F. Parada, and D. R. Kaplan. 1992. Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation. Neuron 9:883-896.
15. Huang, J., M. Mohammadi, G. A. Rodrigues, and J. Schlessinger. 1995. Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis. J. Biol. Chem. 270:5065-5072.
16. Jaye, M., R. M. Lyall, R. Mudd, J. Schlessinger, and N. Sarver. 1988. Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells. EMBO J. 7:963-969.
17. Johnson, D. E., and L. T. Williams. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60:1-41.
18. Kouhara, H., Y. R. Hadari, T. Spivak-Kroizman, J. Schilling, D. Bar-Sagi, I. Lax, and J. Schlessinger. 1997. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89:693-702.
19. Lin, H. Y., J. Xu, D. M. Ornitz, S. Halegoua, and M. J. Hayman. 1996. The fibroblast growth factor receptor-1 is necessary for the induction of neurite outgrowth in PC12 cells by aFGF. J. Neurosci. 16:4579-4587.
20. Mason, I. J. 1994. The ins and outs of fibroblast growth factors. Cell 78:547-552.
21. Mathey-Prevot, B., G. Nabel, R. Palacios, and D. Baltimore. 1986. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol. Cell. Biol. 6:4133-4135.
22. Mobley, W. C., A. Schenker, and E. M. Shooter. 1976. Characterization and isolation of proteolytically modified nerve growth factor. Biochemistry 15: 5543-5552.
23. Mohammadi, M., I. Dikic, A. Sorokin, W. H. Burgess, M. Jaye, and J. Schlessinger. 1996. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:977-989.
24. Muenke, M., and U. Schell. 1995. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11:308-313.
25. Naski, M. C., Q. Wang, J. Xu, and D. M. Ornitz. 1996. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13:233-237.
26. Obermeier, A., R. A. Bradshaw, K. Seedorf, A. Choidas, J. Schlessinger, and A. Ullrich. 1994. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding site for SHC and PLC gamma. EMBO J. 13:1585-1590.
27. Ornitz, D. M., and P. Leder. 1992. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267: 16305-16311.
28. Ornitz, D. M., A. Yayon, J. G. Flanagan, C. M. Svahn, E. Levi, and P. Leder. 1992. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12:240-247.
29. Ornitz, D. M., J. Xu, J. S. Colvin, D. G. McEwen, C. A. MacArthur, F. Coulier, G. Gao, and M. Goldfarb. 1996. Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271:15292-15297.
30. Palacios, R., and M. Steinmetz. 1985. IL3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727-734.
31. Peng, X., L. A. Greene, D. R. Kaplan, and R. M. Stephens. 1995. Deletion of a conserved juxtamembrane sequence in Trk abolishes NGF-promoted neuritogenesis. Neuron 15:395-406.
32. Prinos, P., T. Costa, A. Sommer, M. W. Kilpatrick, and P. Tsipouras. 1995. A common FGFR3 gene mutation in hypochondroplasia. Hum. Mol. Genet. 4:2097-2101.
33. Qui, M. S., and S. H. Green. 1992. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9:705-717.
34. Rousseau, F., J. Bonaventure, L. Legeai-Mallet, A. Pelet, J. M. Rozet, P. Maroteaux, M. Le Merrer, and A. Munnich. 1994. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371: 252-254.
35. Segatto, O., F. Lonardo, D. Wexler, F. Fazioli, J. H. Pierce, D. P. Bottaro, M. F. White, and P. P. Di Fiore. 1991. The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction. Mol. Cell. Biol. 11:3191-3202.
36. Shiang, R., L. M. Thompson, Y. Z. Zhu, D. M. Church, T. J. Fielder, M. Bocian, S. T. Winokur, and J. J. Wasmuth. 1994. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342.
37. Spivak-Kroizman, T., M. Mohammadi, P. Hu, M. Jaye, J. Schlessinger, and I. Lax. 1994. Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells. J. Biol. Chem. 269:14419-14423.
38. Stephens, R. M., D. M. Loeb, T. D. Copeland, T. Pawson, L. A. Greene, and D. R. Kaplan. 1994. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron 12:691-705.
39. Tavormina, P. L., D. L. Rimoin, D. H. Cohn, Y. Z. Zhu, R. Shiang, and J. J. Wasmuth. 1995. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum. Mol. Genet. 4:2175-2177.
40. Tavormina, P. L., R. Shiang, L. M. Thompson, Y. Z. Zhu, D. J. Wilkin, R. S. Lachman, W. R. Wilcox, D. L. Rimoin, D. H. Cohn, and J. J. Wasmuth. 1995. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9:321-328.
41. Terada, K., Y. Kaziro, and T. Satoh. 1995. Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line, BaF3. J. Biol. Chem. 270:27880-27886.
42. Traverse, S., K. Seedorf, H. Paterson, C. J. Marshall, P. Cohen, and A. Ullrich. 1994. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4:694-701.
43. Van Beveren, C., F. van Straaten, T. Curran, R. Muller, and I. M. Verma. 1983. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell 32:1241-1255.
44. Wang, J. K., G. Gao, and M. Goldfarb. 1994. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol. Cell. Biol. 14:181-188.
45. Wang, J. K., and M. Goldfarb. 1997. Amino acid residues which distinguish the mitogenic potentials of two FGF receptors. Oncogene 14:1767-1778.
46. Webster, M. K., and D. J. Donoghue. 1996. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15:520-527.
47. Wilkie, A. O., G. M. Morriss-Kay, E. Y. Jones, and J. K. Heath. 1995. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5:500-507.
48. Yamaguchi, T. P., K. Harpal, M. Henkemeyer, and J. Rossant. 1994. FGFR-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev. 8:3032-3044.
49. Yayon, A., M. Klagsbrun, J. D. Esko, P. Leder, and D. M. Ornitz. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848.